Photodynamic agents with anti-metastatic activities

ACS Chemical Biology

Volumn 8, Issue 8, 2013, Pages 1737-1746

  Vummidi, Balayeshwanth R ^a   Noreen, Faiza ^a   Alzeer, Jawad ^a   Moelling, Karin ^a   Luedtke, Nathan W ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PHTHALOCYANINE ZINC; SINGLET OXYGEN; TETRAKIS (DIISOPROPYL GUANIDINE)PHTHALOCYANINE; TETRAKIS (DIISOPROPYL GUANIDINO)ZINC PHTHALOCYANINE; UNCLASSIFIED DRUG; ZINC PHTHALOCYANINE TETRASULFONATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL MIGRATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; ENDOCYTOSIS; EXCITATION; FEEDBACK SYSTEM; LASER; LUMINESCENCE; METASTASIS; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTUM YIELD; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL PROLIFERATION; LUNG NEOPLASMS; MELANOMA; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; PHOTOSENSITIZING AGENTS;

EID: 84882762291     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400008t     Document Type: Article

References (57)

1. Linos, E., Swetter, S. M., Cockburn, M. G., Colditz, G. A., and Clarke, C. A. (2009) Increasing burden of melanoma in the United States J. Invest. Dermatol. 129, 1666-1674
2. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. (2001) Cancer statistics, 2001 Ca-Cancer J. Clin. 51, 15-36
3. Wargo, J. A. and Tanabe, K. (2009) Surgical management of melanoma Hematol. Oncol. Clin. North Am. 23, 565-581
4. Brown, S. B., Brown, E. A., and Walker, I. (2004) The present and future role of photodynamic therapy in cancer treatment Lancet Oncol. 5, 497-508
5. Sheleg, S. V., Zhavrid, E. A., Khodina, T. V., Kochubeev, G. A., Istomin, Y. P., Chalov, V. N., and Zhuravkin, I. N. (2004) Photodynamic therapy with chlorin e(6) for skin metastases of melanoma Photodermatol. Photoimmunol. Photomed. 20, 21-26
6. Fasanella, K. E. and McGrath, K. (2009) Successful palliative treatment of duodenal metastatic melanoma with photodynamic therapy Gastrointest. Endosc. 69, 182-184
7. Robertson, C. A., Evans, D. H., and Abrahamse, H. (2009) Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT J. Photochem. Photobiol. B 96, 1-8
8. De Rosa, F. S. and Bentley, M. V. (2000) Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives Pharm. Res. 17, 1447-1455
9. Allison, R. R., Downie, G. H., Cuenca, R., Hu, X.-H., Childs, C. J. H., and Sibata, C. H. (2004) Photosensitizers in clinical PDT Photodiagn. Photodyn. Ther. 1, 27-42
10. Cordoba, F., Braathen, L. R., Weissenberger, J., Vallan, C., Kato, M., Nakashima, I., Weis, J., and von Felbert, V. (2005) 5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma Exp. Dermatol. 14, 429-437
11. Karunakaran, S. C., Babu, P. S., Madhuri, B., Marydasan, B., Paul, A. K., Nair, A. S., Rao, K. S., Srinivasan, A., Chandrashekar, T. K., Rao, C. M., Pillai, R., and Ramaiah, D. (2012) In vitro demonstration of apoptosis-mediated photodynamic activity and NIR nucleus imaging through a novel porphyrin ACS Chem. Biol. 8, 127-132
12. Kato, H., Furukawa, K., Sato, M., Okunaka, T., Kusunoki, Y., Kawahara, M., Fukuoka, M., Miyazawa, T., Yana, T., Matsui, K., Shiraishi, T., and Horinouchi, H. (2003) Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung Lung Cancer 42, 103-111
13. Tekdas, D. A., Kumru, U., Gurek, A. G., Durmus, M., Ahsen, V., and Dumoulin, F. (2012) Towards near-infrared photosensitisation: a photosensitising hydrophilic non-peripherally octasulfanyl-substituted Zn phthalocyanine Tetrahedron Lett. 53, 5227-5230
14. Leznoff, C. C. and Lever, A. B. P. (1989-1996) Phthalocyanines-Properties and Applications, Vols. I-IV, VCH, New York.
15. Huang, Y., Xu, G., Peng, Y., Lin, H., Zheng, X., and Xie, M. (2007) Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization J. Ocul. Pharmacol. Ther. 23, 377-386
16. Baron, E. D., Malbasa, C. L., Santo-Domingo, D., Fu, P., Miller, J. D., Hanneman, K. K., Hsia, A. H., Oleinick, N. L., Colussi, V. C., and Cooper, K. D. (2010) Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial Lasers Surg. Med. 42, 728-735
17. Kimani, S. G., Shmigol, T. A., Hammond, S., Phillips, J. B., Bruce, J. I., Macrobert, A. J., Malakhov, M. V., and Golding, J. P. (2013) Fully protected glycosylated zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells Photochem. Photobiol. 89, 139-149
18. Dumoulin, F., Durmus, M., Ahsen, V., and Nyokong, T. (2010) Synthetic pathways to water-soluble phthalocyanines and close analogs Coord. Chem. Rev. 254, 2792-2847
19. Alzeer, J., Roth, P. J., and Luedtke, N. W. (2009) An efficient two-step synthesis of metal-free phthalocyanines using a Zn(II) template Chem. Commun. (Cambridge) 1970-1971
20. Alzeer, J., Vummidi, B. R., Roth, P. J., and Luedtke, N. W. (2009) Guanidinium-modified phthalocyanines as high-affinity G-quadruplex fluorescent probes and transcriptional regulators Angew. Chem., Int. Ed. 48, 9362-9365
21. Membrino, A., Paramasivam, M., Cogoi, S., Alzeer, J., Luedtke, N. W., and Xodo, L. E. (2010) Cellular uptake and binding of guanidine-modified phthalocyanines to KRAS/HRAS G-quadruplexes Chem. Commun. (Cambridge) 46, 625-627
22. Papassava, P., Gorgoulis, V. G., Papaevangeliou, D., Vlahopoulos, S., van Dam, H., and Zoumpourlis, V. (2004) Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors Cancer Res. 64, 8573-8584
23. Miethe, J, S. C., Wottrich, K., Wenning, D., and Klempnauer, K. H. (2001) Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2 Oncogene 20, 8116-8124
24. Zhuang, D, M. S., Grachtchouk, V., Tang, W. H., Patil, S., Wawrzyniak, J. A., Berman, A. E., Giordano, T. J., Prochownik, E. V., Soengas, M. S., and Nikiforov, M. A. (2008) C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells Oncogene 27, 6623-6634
25. Walser, T. C., Rifat, S., Ma, X., Kundu, N., Ward, C., Goloubeva, O., Johnson, M. G., Medina, J. C., Collins, T. L., and Fulton, A. M. (2006) Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer Cancer Res. 66, 7701-7707
26. Wijtmans, M., Verzijl, D., Leurs, R., de Esch, I. J., and Smit, M. J. (2008) Towards small-molecule CXCR3 ligands with clinical potential ChemMedChem 3, 861-872
27. Cambien, B., Karimdjee, B. F., Richard-Fiardo, P., Bziouech, H., Barthel, R., Millet, M. A., Martini, V., Birnbaum, D., Scoazec, J. Y., Abello, J., Al Saati, T., Johnson, M. G., Sullivan, T. J., Medina, J. C., Collins, T. L., Schmid-Alliana, A., and Schmid-Antomarchi, H. (2009) Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism Br. J. Cancer 100, 1755-1764
28. Wender, P. A., Galliher, W. C., Goun, E. A., Jones, L. R., and Pillow, T. H. (2008) The design of guanidinium-rich transporters and their internalization mechanisms Adv. Drug Delivery Rev. 60, 452-472
29. Griffiths, J., Cruse-Sawyer, J., Wood, S. R., Schofield, J., Brown, S. B., and Dixon, B. (1994) On the photodynamic therapy action spectrum of zinc phthalocyanine tetrasulphonic acid in vivo J. Photochem. Photobiol. B 24, 195-199
30. Spikes, J. D. and Bommer, J. C. (1986) Zinc tetrasulphophthalocyanine as a photodynamic sensitizer for biomolecules Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 50, 41-45
31. Hirohara, S., Obata, M., Ogata, S., Kajiwara, K., Ohtsuki, C., Tanihara, M., and Yano, S. (2006) Sugar-dependent aggregation of glycoconjugated chlorins and its effect on photocytotoxicity in HeLa cells J. Photochem. Photobiol. B 84, 56-63
32. Musil, Z., Zimcik, P., Miletin, M., Kopecky, K., Link, M., Petrik, P., and Schwarz, J. (2006) Synthesis and singlet oxygen production of azaphthalo-cyanines bearing functional derivatives of carboxylic acid J. Porphyrins Phthalocyanines 10, 122-131
33. Kuznetsova, N. A., Gretsova, N. S., Derkacheva, V. M., Kaliya, O. L., and Lukyanets, E. A. (2003) Sulfonated phthalocyanines: aggregation and singlet oxygen quantum yield in aqueous solutions J. Porphyrins Phthalocyanines 7, 147-154
34. De Rosa, M. C. and Cruthcley, R. J. (2002) Photosensitized singlet oxygen and its applications Coord. Chem. Rev. 233, 354-371
35. Jensen, N. A., Pedersen, K. M., Lihme, F., Rask, L., Nielsen, J. V., Rasmussen, T. E., and Mitchelmore, C. (2003) Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas J. Biol. Chem. 278, 8300-8308
36. Zhang, X., Lee, C., Ng, P. Y., Rubin, M., Shabsigh, A., and Buttyan, R. (2000) Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein Prostate 43, 278-285
37. Schultz, J., Pavlovic, J., Strack, B., Nawrath, M., and Moelling, K. (1999) Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA Hum. Gene Ther. 10, 407-417
38. Noreen, F., Heinrich, J., and Moelling, K. (2009) Antitumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA in malignant melanoma cells Oligonucleotides 19, 169-178
39. Pandha, H. S., Heinemann, L., Simpson, G. R., Melcher, A., Prestwich, R., Errington, F., Coffey, M., Harrington, K. J., and Morgan, R. (2009) Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma Clin. Cancer Res. 15, 6158-6166
40. Sun, D., Guo, K., and Shin, Y. J. (2011) Evidence of the formation of G-quadruplex structures in the promoter region of the human vascular endothelial growth factor gene Nucleic Acids Res. 39, 1256-1265
41. Xu, Y. and Sugiyama, H. (2006) Formation of the G-quadruplex and i-motif structures in retinoblastoma susceptibility genes (Rb) Nucleic Acids Res. 34, 949-954
42. Lee, J. H., Kim, H. N., Kim, K. O., Jin, W. J., Lee, S., Kim, H. H., Ha, H., and Lee, Z. H. (2012) CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis Cancer Res. 72, 3175-3186
43. Booth, V., Keizer, D. W., Kamphuis, M. B., Clark-Lewis, I., and Sykes, B. D. (2002) The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions Biochemistry 41, 10418-10425
44. Jabeen, T., Leonard, P., Jamaluddin, H., and Acharya, K. R. (2008) Structure of mouse IP-10, a chemokine Acta Crystallogr., Sect. D: Biol. Crystallogr. 64, 611-619
45. Heise, C. E., Pahuja, A., Hudson, S. C., Mistry, M. S., Putnam, A. L., Gross, M. M., Gottlieb, P. A., Wade, W. S., Kiankarimi, M., Schwarz, D., Crowe, P., Zlotnik, A., and Alleva, D. G. (2005) Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist J. Pharmacol. Exp. Ther. 313, 1263-1271
46. Sauty, A., Colvin, R. A., Wagner, L., Rochat, S., Spertini, F., and Luster, A. D. (2001) CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11) J. Immunol. 167, 7084-7093
47. Meiser, A., Mueller, A., Wise, E. L., McDonagh, E. M., Petit, S. J., Saran, N., Clark, P. C., Williams, T. J., and Pease, J. E. (2008) The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor J. Immunol. 180, 6713-6724
48. Kawada, K., Sonoshita, M., Sakashita, H., Takabayashi, A., Yamaoka, Y., Manabe, T., Inaba, K., Minato, N., Oshima, M., and Taketo, M. M. (2004) Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes Cancer Res. 64, 4010-4017
49. Martins, V. L., Vyas, J. J., Chen, M., Purdie, K., Mein, C. A., South, A. P., Storey, A., McGrath, J. A., and O'Toole, E. A. (2009) Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen J. Cell Sci. 122, 1788-1799
50. Yoshida, R., Nagira, M., Kitaura, M., Imagawa, N., Imai, T., and Yoshie, O. (1998) Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7 J. Biol. Chem. 273, 7118-7122
51. Bhatia, S., Tykodi, S. S., and Thompson, J. A. (2009) Treatment of metastatic melanoma: an overview Oncology 23, 488-496
52. Ometto, C., Fabris, C., Milanesi, C., Jori, G., Cook, M. J., and Russell, D. A. (1996) Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine Br. J. Cancer. 74, 1891-1899
53. Wendel, M., Galani, I. E., Suri-Payer, E., and Cerwenka, A. (2008) Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands Cancer Res. 68, 8437-8445
54. Saudemont, A., Jouy, N., Hetuin, D., and Quesnel, B. (2005) NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells Blood 105, 2428-2435
55. Antonicelli, F., Lorin, J., Kurdykowski, S., Gangloff, S. C., Le Naour, R., Sallenave, J. M., Hornebeck, W., Grange, F., and Bernard, P. (2011) CXCL10 reduces melanoma proliferation and invasiveness in vitro and in vivo Br. J. Dermatol. 164, 720-728
56. Pfeiffer, R., Kirsch, J., and Fahrenholz, F. (1998) Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor Exp. Cell Res. 244, 327-339
57. Pheng, L. H., Dumont, Y., Fournier, A., Chabot, J. G., Beaudet, A., and Quirion, R. (2003) Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells Br. J. Pharmacol. 139, 695-704